Overdose a risk of transdermal patch in diverse settings

Canadian Pharmacists Journal

Volumn 138, Issue 7, 2005, Pages 65-66

  Wichman, Kristina ^a   U, David ^a  

^a ISMP Canada   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIHISTAMINIC AGENT; FENTANYL; MUSCLE RELAXANT AGENT; TRANQUILIZER;

ADOLESCENT; AGED; CANADA; CASE REPORT; CONFUSION; DIZZINESS; DRUG ADMINISTRATION ROUTE; DRUG FATALITY; DRUG FORMULATION; DRUG OVERDOSE; DRUG SAFETY; DYSPNEA; FAINTNESS; FEMALE; GOOD CLINICAL PRACTICE; HEAT; HUMAN; LONG TERM CARE; MEDICATION ERROR; PAIN; PATIENT SELECTION; RECURRENT DISEASE; SHORT SURVEY; SOMNOLENCE;

EID: 30644459885     PISSN: 17151635     EISSN: None     Source Type: Journal    
DOI: 10.1177/171516350513800709     Document Type: Short Survey

References (10)

1. Baker GR, Norton PG, Flintoft V, et al. The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. CMAJ 2004;170(11):1678-86.
2. Forster AJ, Clark HD, Menard A, et al. Adverse events among medical patients after discharge from hospital. CMAJ 2004;170(3):345-9.
3. Forster AJ, Asmis TR, Clark HD, et al. Ottawa Hospital Patient Safety Study: incidence and timing of adverse events in patients admitted to a Canadian teaching hospital. CMAJ 2004;170(8):1235-40.
4. Cornish PL, Knowles SR, Marchesano R, et al. Unintended medication discrepancies at the time of hospital admission. Arch Intern Med 2005;165:424-9.
5. Gurwitz JH, Field TS, Judge J, et al. The incidence of adverse drug events in two large academic long-term care facilities. Am J Med 2005;118(3):251-8.
6. ISMP's list of high-alert medications. Huntingdon Valley (PA): Institute for Safe Medication Practices; 2005. Available: www.ismp.org/Tools/ highalertmedications.pdf (accessed Sept. 16, 2005).
7. Little patches...big problems. New safety warnings about fentanyl patches - Part 1. ISMP Medication Safety Alert Community/Ambulatory Edition 2005;4(8):1-3.
8. Little patches...big problems. New safety warnings about fentanyl patches-Part 2. ISMP Medication Safety Alert Community/Ambulatory Edition2005;4(9):1-3.
9. Transdermal fentanyl (Duragesic): respiratory arrest in adolescents. Can Adverse React Newsl 2004;14(4). Available: www.hc-sc.gc.ca/dhp-mps/medeff/ bulletin/carn-bcei_vl4n4_e.html (accessed Sept. 26, 2005).
10. Health Canada. Public Advisory. Duragesic (fentanyl transdermal system) Safety Information. Available: www.hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/ public/duragesic_pa-ap_e.html (accessed Sept. 26, 2005).